PI3K

Phosphoinositide 3-kinases (PI3Ks) are lipid kinases that catalyze the phosphorylation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) to generate the second messenger phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P₃). The production of PI(3,4,5)P₃ facilitates the recruitment and activation of pleckstrin homology (PH) domain–containing proteins at the plasma membrane, thereby initiating downstream signaling cascades essential for cellular proliferation, survival, and migration.

PI3Ks are divided into three major classes, among which Class I PI3Ks are most prominently implicated in cancer biology. Class I enzymes comprise four distinct catalytic isoforms: PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ.

Class IA PI3Ks, the subclass most commonly associated with oncogenic signaling, function as heterodimeric lipid kinases composed of a catalytic p110 subunit (p110α, p110β, or p110δ, encoded by PIK3CA, PIK3CB, and PIK3CD, respectively) and a regulatory p85 subunit.

The PI3K signaling pathway plays a central role in diverse biological processes, including cell cycle progression, cellular growth, survival, actin cytoskeletal rearrangement, migration, and intracellular vesicular trafficking.

Frequently Asked Questions
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that phosphorylate phosphatidylinositol lipids to regulate cell growth, survival, metabolism, and immune signaling. PI3K activation leads to downstream AKT and mTOR pathway signaling. Aberrant PI3K signaling is frequently observed in cancer due to PIK3CA mutations, PTEN loss, or receptor tyrosine kinase activation.
Class I PI3Ks include four catalytic isoforms: PI3Kα (PIK3CA) PI3Kβ (PIK3CB) PI3Kδ (PIK3CD) PI3Kγ (PIK3CG) PI3Kα and β are broadly expressed, while PI3Kδ and γ are enriched in leukocytes and play critical roles in immune regulation. Isoform selectivity is an important consideration in drug development due to toxicity and immune effects.
PI3K inhibitors can be classified as: Pan-PI3K inhibitors Isoform-selective inhibitors (α, β, δ, γ) Dual PI3K/mTOR inhibitors Irreversible inhibitors Selectivity influences therapeutic window and toxicity profile.
While PI3K inhibitors block upstream lipid kinase activity, mTOR inhibitors act downstream at the level of mTORC1 or mTORC2. Dual PI3K/mTOR inhibitors target both nodes of the pathway and may achieve broader pathway suppression.

Items 301-325 of 411

  • Roginolisib
    Cat. No.
    A79784

    Roginolisib

    Synonyms: MSC2360844; IOA-244

    Roginolisib is a selective PI3Kδ inhibitor that exhibits potent activity with an IC50 of 145 nM. This compound demonstrates high selectivity against a broad panel of 278 additional kinases, making it a valuable tool for research in cell signaling pathways. Its application in studies targeting immune responses and cancer biology highlights the importance of PI3Kδ modulation in therapeutic development.

    1 mg
    $40.00
    5 mg
    $95.00
    All 7 sizes
  • PI3Kγ inhibitor AZ2
    Cat. No.
    A79786

    PI3Kγ inhibitor AZ2

    PI3Kγ inhibitor AZ2 selectively targets phosphoinositide 3-kinase gamma (PI3Kγ) with a pIC50 value of 9.3, indicating potent inhibition. This compound is valuable for investigating the role of PI3Kγ in inflammatory and immune diseases, providing insights into potential therapeutic applications. Its specificity makes it a useful tool in biochemical and pharmacological studies related to immune regulation.

    1 mg
    $80.00
    5 mg
    $205.00
    All 6 sizes
  • AMG 511
    Cat. No.
    A79787

    AMG 511

    AMG 511 is a potent pan-inhibitor of class I phosphoinositide 3-kinases (PI3Ks), demonstrating inhibitory constants (Kis) of 4 nM, 6 nM, 2 nM, and 1 nM for PI3Kα, β, δ, and γ, respectively. This compound effectively suppresses PI3K signaling, as evidenced by a decrease in phosphorylated Akt (Ser473). AMG 511 has shown significant anti-tumor activity in mouse models of glioblastoma, making it a valuable tool for cancer research and therapeutic development.

    1 mg
    $65.00
    2 mg
    $90.00
    All 3 sizes
  • Duvelisib (R enantiomer)
    Cat. No.
    A79788

    Duvelisib (R enantiomer)

    Synonyms: IPI-145 R enantiomer; INK1197 R enantiomer

    Duvelisib (R enantiomer) is a selective inhibitor of phosphoinositide 3-kinase (PI3K), targeting the delta and gamma isoforms. It exhibits antitumor activity by inhibiting cell proliferation and promoting apoptosis in various cancer models. This compound is primarily utilized in research focused on cancer treatment, immune response modulation, and signaling pathway analysis.

    5 mg
    $80.00
    10 mg
    $120.00
    All 5 sizes
  • PF-06843195
    Cat. No.
    A79789

    PF-06843195

    PF-06843195 is a highly selective inhibitor of the PI3Kα isoform, exhibiting an IC50 of 18 nM in Rat1 fibroblasts. With kinase inhibition constants (Kis) of less than 0.018 nM and 0.28 nM for PI3Kα and PI3Kδ respectively, this compound effectively suppresses the PI3K/mTOR signaling pathway. PF-06843195 demonstrates significant antitumor efficacy, making it a valuable tool for research applications targeting cancer biology and therapeutic development.

    2 mg
    $25.00
    5 mg
    $65.00
    All 3 sizes
  • MIPS-21335
    Cat. No.
    A79790

    MIPS-21335

    MIPS-21335 is a selective inhibitor of PI3KC2α, exhibiting an IC50 value of 7 nM. Additionally, it demonstrates inhibition of PI3KC2β, p110α, p110β, and p110δ, with corresponding IC50 values of 43, 140, 386, and 742 nM. MIPS-21335 exhibits significant antithrombotic effects and is valuable for research into cardiovascular and metabolic diseases, including thrombosis and hyperlipidemia.

    5 mg
    $305.00
    10 mg
    $505.00
    All 4 sizes
  • AZD8154
    Cat. No.
    A79792

    AZD8154

    AZD8154 is a selective dual inhibitor of the PI3Kγ and PI3Kδ isoforms. By effectively suppressing the activation of these signaling pathways, AZD8154 demonstrates potential in modulating inflammatory responses. This reagent is suitable for research in inflammation and immunology, particularly in studies related to asthma and other related conditions.

    5 mg
    $535.00
    10 mg
    $825.00
    All 5 sizes
  • PIT-1
    Cat. No.
    A79793

    PIT-1

    PIT-1 is a selective inhibitor of phosphatidylinositol 3,4,5-trisphosphate (PIP3) that targets the PI3K/Akt signaling pathway. By inhibiting PIP3, PIT-1 effectively disrupts cancer cell survival and promotes apoptosis. This compound demonstrates significant antitumor activity in vivo, making it suitable for investigations into cancer therapeutics and signaling pathways involved in oncogenesis.

    5 mg
    $25.00
    10 mg
    $30.00
    All 5 sizes
  • (S)-Tersolisib
    Cat. No.
    A79795

    (S)-Tersolisib

    Synonyms: (S)-STX-478; (S)-STX-478-101; (S)-LY4064809

    (S)-Tersolisib is the S-enantiomer of STX-478, a selective inhibitor of PI3Kα mutants. This compound effectively prevents metabolic dysfunction and exhibits notable antitumor activity in xenograft mouse models harboring PI3Kα mutant tumors. It serves as a valuable research tool for studying the therapeutic potential of targeting PI3Kα mutations in cancer.

    1 mg
    $60.00
    5 mg
    $135.00
    All 6 sizes
  • Leniolisib phosphate
    Cat. No.
    A79796

    Leniolisib phosphate

    Synonyms: CDZ173 phosphate

    Leniolisib phosphate is a potent and selective inhibitor of the phosphoinositide 3-kinase delta (PI3Kδ) pathway. This compound exhibits significant biological activity in modulating immune responses, making it a valuable tool for research in immunodeficiency disorders. Its mechanism of action underscores its potential in therapeutic applications targeting underlying immunological defects.

    5 mg
    $170.00
    10 mg
    $295.00
    All 5 sizes
  • PI3K-IN-31
    Cat. No.
    A79797

    PI3K-IN-31

    PI3K-IN-31 is a potent inhibitor of phosphoinositide 3-kinases (PI3K), displaying IC50 values of 3.7 nM for PI3Kα, 74 nM for PI3Kβ, 14.6 nM for PI3Kγ, and 9.9 nM for PI3Kδ. Its selective inhibition of these kinases correlates with significant anticancer activity, making it a valuable tool in cancer research. Applications for PI3K-IN-31 include studying the PI3K signaling pathway and evaluating its role in tumorigenesis and therapeutic resistance.

    5 mg
    $105.00
    10 mg
    $185.00
    All 5 sizes
  • PQR514
    Cat. No.
    A79799

    PQR514

    PQR514 is a potent inhibitor of phosphoinositide 3-kinase (PI3K), demonstrating significant anticancer activity. This compound effectively inhibits cancer cell proliferation and exhibits substantial antitumor effects in the OVCAR-3 xenograft model, with required concentrations notably lower than those of other PI3K inhibitors. PQR514 features favorable pharmacokinetic properties and minimal brain penetration, positioning it as an optimized candidate for targeting systemic tumors in cancer research applications.

    1 mg
    $265.00
    5 mg
    $650.00
    All 5 sizes
  • (S)-PI3Kα-IN-4
    Cat. No.
    A79800

    (S)-PI3Kα-IN-4

    (S)-PI3Kα-IN-4 is a highly selective inhibitor of the phosphoinositide 3-kinase alpha (PI3Kα) isoform, demonstrating an IC50 value of 2.3 nM. This compound exhibits significant selectivity, with 38.3-fold preference for PI3Kα over PI3Kβ, and more than 4-fold selectivity compared to PI3Kδ and PI3Kγ. (S)-PI3Kα-IN-4 is suitable for research applications focusing on cancer biology, particularly in studies aimed at understanding the role of PI3Kα in tumorigenesis and therapeutic resistance.

    5 mg
    $230.00
    10 mg
    $385.00
    All 5 sizes
  • Vulolisib
    Cat. No.
    A79801

    Vulolisib

    Vulolisib is a potent, orally active inhibitor of phosphatidylinositol 3-kinase (PI3K), demonstrating IC50 values of 0.2 nM for PI3Kα, 168 nM for PI3Kβ, 90 nM for PI3Kγ, and 49 nM for PI3Kδ. This compound exhibits significant antiproliferative and antineoplastic properties, making it a valuable tool for cancer research. Its selective inhibition of PI3K isoforms facilitates investigations into the role of PI3K signaling in various malignancies.

    5 mg
    $640.00
    10 mg
    $1,050.00
    All 5 sizes
  • PI3Kδ/γ-IN-1
    Cat. No.
    A79802

    PI3Kδ/γ-IN-1

    PI3Kδ/γ-IN-1 is a selective inhibitor targeting phosphoinositide 3-kinase delta (PI3Kδ) and gamma (PI3Kγ), demonstrating high potency in inhibiting their activity. This compound plays a pivotal role in the study of hematological malignancies, facilitating research into the underlying molecular mechanisms and potential therapeutic approaches for conditions such as leukemia and lymphoma. Its specificity for PI3Kδ and PI3Kγ makes it an invaluable tool for investigating the contributions of these isoforms in cancer biology.

    5 mg
    $260.00
    10 mg
    $435.00
    All 5 sizes
  • NVS-PI3-4
    Cat. No.
    A79803

    NVS-PI3-4

    NVS-PI3-4 is a selective inhibitor of PI3Kγ, playing a crucial role in modulating the PI3K signaling pathway. This compound demonstrates significant inhibitory activity, making it a valuable tool for investigating the mechanisms underlying allergies, inflammatory disorders, and various cancer types. Researchers can utilize NVS-PI3-4 to explore therapeutic strategies aimed at targeting PI3Kγ-related pathways in relevant disease models.

    5 mg
    $125.00
    10 mg
    $200.00
    All 5 sizes
  • Benzoin
    Cat. No.
    A79804

    Benzoin

    Synonyms: DL-Benzoin; Desyl alcohol; (±)-2-Hydroxy-2-phenylacetophenone

    Benzoin is a potent inhibitor of the phosphoinositide 3-kinase alpha (PI3Kα) signaling pathway, known for its potential anticancer effects. This compound has been shown to effectively impede the growth of the colon cancer cell line HCT-116, making it a valuable tool for cancer research. Its application in studying PI3Kα-mediated processes provides insights into therapeutic strategies for colon malignancies.

    1 g
    $20.00
    100 g
    $25.00
    All 4 sizes
  • AS-041164
    Cat. No.
    A79805

    AS-041164

    AS-041164 is a selective inhibitor of the PI3Kγ isoform, demonstrating a potent inhibitory effect with an IC50 of 70 nM. This compound exhibits significantly reduced activity against other isoforms, including PI3Kα, PI3Kβ, and PI3Kδ, with IC50 values of 240 nM, 1.45 μM, and 1.70 μM, respectively. AS-041164 is recognized for its anti-inflammatory properties and is applicable in research focused on inflammation-related pathways and diseases.

    5 mg
    $40.00
    10 mg
    $45.00
    All 5 sizes
  • MIPS-9922
    Cat. No.
    A79806

    MIPS-9922

    MIPS-9922 is a potent and selective inhibitor of PI3Kβ, exhibiting an IC50 of 63 nM. This compound demonstrates over 30-fold higher potency for PI3Kβ compared to PI3Kδ. MIPS-9922 effectively disrupts PI3K-mediated activation of platelet glycoprotein αIIbβ3 and platelet adhesion in vitro, making it a valuable tool for studying anti-platelet and anti-thrombotic activities in research applications.

    5 mg
    $1,040.00
    10 mg
    $1,155.00
    All 5 sizes
  • Parsaclisib hydrochloride
    Cat. No.
    A79807

    Parsaclisib hydrochloride

    Synonyms: INCB050465 hydrochloride; IBI-376 hydrochloride

    Parsaclisib hydrochloride is a selective inhibitor of PI3Kδ, exhibiting an IC50 of 1 nM in the presence of 1 mM ATP. With approximately 20,000-fold selectivity over other PI3K class I isoforms, this orally active compound is valuable for investigating the biochemical pathways involved in B-cell malignancies. It is particularly useful in research focused on relapsed or refractory forms of these cancers.

    1 mg
    $150.00
    5 mg
    $320.00
    All 6 sizes
  • PI3Kα-IN-4
    Cat. No.
    A79808

    PI3Kα-IN-4

    PI3Kα-IN-4 is a selective, potent inhibitor of the phosphoinositide 3-kinase alpha (PI3Kα) with an IC50 value of 1.8 nM. This orally active compound exhibits significant antitumor activity, making it a valuable tool in cancer research. It is primarily used for investigating the role of PI3Kα in oncogenesis and therapeutic resistance.

    5 mg
    $230.00
    10 mg
    $385.00
    All 5 sizes
  • PI3K-IN-36
    Cat. No.
    A79810

    PI3K-IN-36

    PI3K-IN-36 is a potent inhibitor of phosphoinositide 3-kinase (PI3K), a critical enzyme involved in cell signaling pathways. This compound exhibits significant biological activity and is primarily utilized in research focused on follicular lymphoma (FL). Its effectiveness as a PI3K inhibitor makes it a valuable tool for investigating the underlying mechanisms of cancer and testing potential therapeutic strategies.

    5 mg
    $420.00
    10 mg
    $690.00
    All 5 sizes
  • TGX-115
    Cat. No.
    A79811

    TGX-115

    TGX-115 is a selective inhibitor of the p110β and p110δ isoforms of phosphoinositide 3-kinase (PI3-K). It effectively blocks p110β-mediated phosphorylation of Akt in response to lysophosphatidic acid (LPA) in L6 myotubes, and it reduces insulin-stimulated levels of PI(3,4)P2 and PIP3 in 3T3-L1 adipocytes. TGX-115 is a valuable tool for research investigating the mechanisms underlying diabetes mellitus and related metabolic disorders.

    1 mg
    $170.00
    5 mg
    $410.00
    All 7 sizes
  • Roginolisib hemifumarate
    Cat. No.
    A79812

    Roginolisib hemifumarate

    Synonyms: MSC2360844 hemifumarate; IOA-244 hemifumarate

    Roginolisib hemifumarate is a selective inhibitor of the PI3Kδ isoform with an IC50 of 145 nM. This compound demonstrates significant selectivity across a broad panel of 278 additional kinases, making it a valuable tool for the study of signaling pathways involving PI3Kδ. Its potency and specificity facilitate research applications in cancer biology and immune modulation.

    5 mg
    $195.00
    10 mg
    $325.00
    All 5 sizes
  • PI3K-IN-2
    Cat. No.
    A79813

    PI3K-IN-2

    PI3K-IN-2 is a potent and orally bioavailable inhibitor of PI3Kβ and PI3Kδ, exhibiting IC50 values of 7.1 nM and 8.6 nM, respectively. This compound demonstrates excellent selectivity over other isoforms, such as PI3Kσ and PI3Kγ, with IC50 values of 13 nM and 190 nM. Due to its specificity and potency, PI3K-IN-2 is suitable for research applications focusing on cancer, inflammation, and other diseases associated with dysregulated PI3K signaling pathways.

    5 mg
    $470.00
    10 mg
    $805.00
    All 5 sizes

Items 301-325 of 411

Added to your cart

View Cart Checkout

    Loading...